IP Library › Assignment 050180/0219
Patent Assignment
Reel/Frame 050180/0219

Assignment of Assignor's Interest

Recorded: 2019-08-27 Pages: 3
Assignors
QUINN, JOHN FREDERICK
Executed: 2013-09-09
KHLEBNIKOV, VLADIMIR
Executed: 2013-08-06
Assignee
RVX THERAPEUTICS INC.
279 MIDPARK WAY SE, CALGARY, AB, T2X 1M2, CANADA
Covered Property (1)
Novel Quinazolinones as Bromodomain Inhibitors
Application: 15/821,454 →
Publication: US 2018/0092924
Related Assignments (3)
Other recorded transfers of the patent in this record — the chain of ownership.
General Conveyance and Assumption Agreement Aug 27, 2019
From: RVX THERAPEUTICS INC.
To: ZENITH EPIGENETICS CORP.
Reel/Frame 050180/0309 →
Change of Name Aug 27, 2019
From: ZENITH EPIGENETICS CORP.
To: ZENITH CAPITAL CORP.
Reel/Frame 050180/0326 →
Assignment of Assignor's Interest Aug 27, 2019
From: ZENITH CAPITAL CORP.
To: ZENITH EPIGENETICS LTD.
Reel/Frame 050180/0339 →